Novocure's chart data is dated 2026-10-09. There is no active technical signal. There are 5 published signal records.
Novocure last closed at $14.58 (+2.53%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -11.1×. Its overall grade ranks 199 of 738 stocks in Healthcare.
About this company
Novocure last closed at $14.58 (+2.53%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 199/738
Valuation grade B
Related stocks
- Boston ScientificCompetitor
암 치료용 전기장 치료(온코로지) 및 의료기기 영역에서 경쟁
- Bristol-Myers SquibbCompetitor
종양학 치료 시장에서 주요 항암제 개발·판매 경쟁
- MerckCompetitor
암 치료제(면역항암제 포함) 분야의 핵심 경쟁사
About Novocure
- What technical signals does Novocure (NVCR) have?
- Novocure current technical signals: no active technical signal.
- Is Novocure a cup-and-handle pattern?
- No. Novocure has no valid Cup signal right now.
- What published figures are available for Novocure?
- Market cap: $1.63B. Trailing 12 months PER: -11.1×. Latest quarter PBR: 4.88×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Novocure, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.